Nasal spray fights senile dementia: Scientists discover drug that reverses brain aging

For decades, "neuroinflammatory aging"—a slow-burning inflammation that causes brain fog and memory loss—was considered an inevitable part of aging. However, it can be avoided, writes Neuroscience News.

Researchers have developed a non-invasive nasal spray that uses microscopic "delivery particles" that penetrate directly into the brain. Just two doses of the therapy dramatically reduced chronic inflammation, recharged cellular "power plants" (mitochondria), and restored memory and cognitive clarity.

Tiny pockets of inflammation fester deep within the brain's memory center, creating a persistent "brain fog." This makes it difficult to think, form new memories, and even adapt to new conditions. This inflammation also increases the risk of disorders like Alzheimer's.

Scientists call this slow process "neuroinflammatory aging." For decades, it was thought to be inevitable.

On the subject: Half of US residents are at increased risk of developing dementia: what is the reason

However, a landmark study by scientists from the Naresh K. Vashisht College of Medicine at Texas A&M University has shown that the inflammatory process responsible for brain aging and "brain fog" can be reversed. And the solution doesn't require brain surgery—a simple nasal spray is all it takes.

Led by Dr. Ashok Shetty, Distinguished Professor at the university and Deputy Director of the Institute for Regenerative Medicine, and Senior Research Fellows Dr. Madhu Lilavati Narayana and Dr. Mahidhar Kodali, the team developed a nasal spray that, in just two doses, significantly reduces brain inflammation, restores cellular power plants, and significantly improves memory.

The most amazing thing is that memory was restored within a few weeks after two inhalations, and the effect lasted for months.

The findings, published in the Journal of Extracellular Vesicles, could change the future of neurodegenerative disease treatments and even scientists' understanding of brain aging.

"Age-related brain diseases like dementia are a major public health problem worldwide," Shetty said. "We show that brain aging can be reversed to help people maintain mental clarity."

From Brain Fog to Clearer Thinking: The Future of Cognitive Therapy

The implications of this research could be truly revolutionary.

"As this therapy is developed and scaled up, a simple two-dose nasal spray may one day replace invasive and risky procedures or months of drug treatment," he noted.

The societal impact could be no less significant. In the US alone, the number of new cases of dementia is projected to double over the next four decades, from approximately 514000 in 2020 to approximately 1 million in 2060.

“This trend highlights the urgent need for policies and innovative interventions that can minimize both the risk and severity of neurodegenerative disorders such as dementia,” Dr. Shetty said.

The study also points to broad applicability—it found equal effectiveness for both sexes, a rare finding in biomedical research.

"This is a universal drug," the professor assured. "The treatment results were consistent and similar for both sexes."

In the future, this approach may help stroke survivors restore lost brain function or slow down (and possibly reverse) the effects of cognitive aging in humans.

"Our approach reimagines the very concept of aging," Shetty explained. "It's not just about living longer, but also living smarter and healthier lives."

Rewiring the brain from the inside

This discovery is based on millions of microscopic biological "parcels" known as extracellular vesicles (EVs). They act as transport vehicles, carrying a powerful genetic payload—microRNAs.

"MicroRNAs act as master regulators," Narayana explained. "They help modulate and regulate numerous genes and signaling pathways in the brain."

However, the delivery route is no less important.

When placed in a nasal spray, these tiny vesicles bypass the brain's protective barrier and enter directly into the brain tissue, where they are absorbed.

"The delivery method is one of the most exciting aspects of our approach," Kodály emphasized. "Intranasal administration allows us to directly reach and influence the brain without invasive procedures."

Once in the brain's immune cells, microRNAs suppress systems such as the NLRP3 inflammasome and cGAS–STING signaling pathways, which are known to promote chronic inflammation in the aging brain.

At the cellular level, the treatment “recharges” the mitochondria of neurons – the energy stations inside brain cells.

By restoring the function of these cellular "power plants," the therapy not only eliminates "brain fog" but also physically improves the brain's ability to process and retain information.

"We restore the sparkle in neurons by reducing oxidative stress and reactivating brain mitochondria," Narayana concluded.

Behavioral tests confirmed biological changes. The treated models demonstrated significant improvements not only in recognizing familiar objects but also in detecting new objects and changes in the environment—a stark contrast to the control group.

"We're seeing the brain's own repair systems kick in, eliminating inflammation and restoring it," Shetty added.

While further research is needed, the professor and his team have already filed a US patent for the therapy, marking a major milestone toward a potential breakthrough in treating brain aging.

“We’re not just trying to understand biological mechanisms—we’re translating and developing our findings into real-world treatments that can change lives,” Shetty concluded.

You may be interested in: top New York news, stories of our immigrants, and helpful tips about life in the Big Apple - read it all on ForumDaily New York

With support from the National Institute on Aging (NIA), a team at Texas A&M University has pooled knowledge, expertise, and resources to transform a simple nasal spray into a therapy that could change how scientists understand the aging brain.

Despite the revolutionary results, the development is still in the research and patenting phase. However, since the method is non-invasive and equally effective for both sexes, clinical trials are expected soon.

Read also on ForumDaily:

Old age begins at 30: 5 factors influencing biological age

Stop, moment: why do we think that with age, time runs faster

No more glasses: FDA approves revolutionary eye drops for farsightedness

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Social media coordinator- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis.